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This study used immunohistochemical methods to investigate the possibility that
hypothalamic neurons that contain 11-β-hydroxysteroid dehydrogenase type 2 (HSD2)
are involved in the control of feeding by rats via neuroanatomical associations with
the α subtype of estrogen receptor (ERα), catecholamines, and/or oxytocin (OT).
An aggregate of HSD2-containing neurons is located laterally in the hypothalamus,
and the numbers of these neurons were greatly increased by estradiol treatment
in ovariectomized (OVX) rats compared to numbers in male rats and in OVX rats
that were not given estradiol. However, HSD2-containing neurons were anatomically
segregated from ERα-containing neurons in the Ventromedial Hypothalamus and the
Arcuate Nucleus. There was an absence of OT-immunolabeled fibers in the area
of HSD2-labeled neurons. Taken together, these findings provide no support for
direct associations between hypothalamic HSD2 and ERα or OT neurons in the
control of feeding. In contrast, there was catecholamine-fiber labeling in the area
of HSD2-labeled neurons, and these fibers occasionally were in close apposition
to HSD2-labeled neurons. Therefore, we cannot rule out interactions between
HSD2 and catecholamines in the control of feeding; however, given the relative
sparseness of the appositions, any such interaction would appear to be modest.
Thus, these studies do not conclusively identify a neuroanatomical substrate by
which HSD2-containing neurons in the hypothalamus may alter feeding, and leave
the functional role of hypothalamic HSD2-containing neurons subject to further
investigation.
Keywords: ventromedial hypothalamic nucleus, arcuate nucleus, lateral hypothalamic area, paraventricular
hypothalamic nucleus, sex differences
Introduction
A population of neurons containing 11-β-hydroxysteroid dehydrogenase type 2 (HSD2)
have been reported to be located in the ventromedial hypothalamus (VMH; Geerling et al.,
2006b). Although the functional role of these neurons is unclear, it is known that HSD2
facilitates binding of aldosterone to mineralocorticoid receptors (MRs; Náray-Fejes-Tóth
et al., 1998). In fact, HSD2-containing neurons in the hindbrain nucleus of the solitary tract
(NTS) have been implicated in sodium ingestion in response to sodium deficiency (Geerling
et al., 2006a; Geerling and Loewy, 2007), which is accompanied by increased aldosterone
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levels. These observations raise the possibility that HSD2-
containing neurons in the VMH also may confer sensitivity to
aldosterone and therebymediate behavioral responses to changes
in sodium state. However, alternative possibilities exist. One such
possibility is suggested by extensive evidence converging on the
role of hypothalamic areas, including the VMH, in the central
control of energy balance (Woods and Stricker, 2008). Classic
studies in the 1940s and 1950s demonstrated that electrolytic
lesions of the VMH cause hyperphagia, increased adiposity,
and increased body weight (Hetherington and Ranson, 1940,
1942; Anand and Brobeck, 1951). With more sophisticated
experimental approaches, better understanding of the role of the
VMH and other hypothalamic areas in the control of feeding and
body weight has emerged, particularly in regard to the neuronal
phenotypes that mediate these effects.
Interactions among neuropeptide Y (NPY), agouti gene
related peptide (AgRP), and proopiomelanocortin (POMC)
neurons in the arcuate nucleus (ARC) have been the subject
of much investigation (Schwartz et al., 2000; Woods and
D’Alessio, 2008), as has the role of the neuropeptide oxytocin
(OT; Olson et al., 1991; Verbalis et al., 1993; Uchoa et al.,
2009; Olszewski et al., 2010; Sabatier et al., 2013), and
catecholamines (Schwartz et al., 2000; Wellman, 2000; Palmiter,
2007). Recently, attention has turned to the role of estradiol
and hypothalamic estrogen receptors (ERs) in energy balance.
Estradiol is well-known to influence feeding and body weight.
Specifically, adult female rats display cyclic changes in feeding
that correspond to estrous cycling (Blaustein and Wade,
1976; Eckel et al., 2000). Moreover, removal of endogenous
estradiol by ovariectomy promotes hyperphagia and weight
gain in rats, both of which are reversed by estradiol treatment
(Wade, 1972; Blaustein and Wade, 1976; Roy and Wade,
1977; Geary and Asarian, 1999; Krause et al., 2006). As a
steroid hormone, estradiol readily accesses the central nervous
system (CNS) and acts at ERs that are broadly distributed
throughout the CNS (Simerly et al., 1990; Shughrue et al.,
1997; Laflamme et al., 1998). The alpha subtype of ERs
(ERα) has been implicated in the control of food intake
(Roesch, 2006; Santollo et al., 2007, 2010), and a particularly
dense population of ERα exists in the hypothalamic VMH.
Indeed, in an interesting parallel to classic VMH lesion
studies, Musatov and colleagues used siRNA methods to
selectively prevent expression of ERα in the VMH and
found that rats over-ate and gained excess weight, while
physical activity and metabolic rate decreased (Musatov et al.,
2007).
A tantalizing possibility for interactions between estradiol
and HSD2-containing neurons in the VMH is suggested by our
recent findings that estradiol treatment increased the number of
HSD2-containing neurons in the NTS of ovariectomized (OVX)
rats (Fan et al., 2010). But is it possible that neuroanatomical
associations between HSD2 and estradiol in the VMH are
involved in the control of feeding via ERα? If so, several
outcomes might be envisioned. First, one might predict co-
localization of ERα and HSD2 in VMH neurons. An alternative
outcome, based on the ability of estrogens to alter gene
transcription (e.g., Marino et al., 2006), would be changes in
the numbers of HSD2 neurons, and/or in HSD2 synthesis that
parallel changes in estradiol levels. Finally, HSD2 may interact
indirectly with other neurotransmitters in the hypothalamus
to alter estradiol-mediated effects on food intake. Clearly,
these are not mutually exclusive possibilities, nor are they
intended to be exhaustive. Rather, given the comparative dearth
of information about hypothalamic HSD2-containing neurons,
these ideas are intended to serve as a ‘‘jumping off’’ point
in exploring the role of HSD2-containing neurons in the
hypothalamus. Accordingly, based upon connections among
these hypothalamic areas and on our report of increased
number of HSD2-containing neurons in the NTS after estradiol
treatment (Fan et al., 2010), we began with the hypothesis
that interactions between hypothalamic HSD2 and estradiol
are important in the control of feeding. This hypothesis,
therefore, is the basis of these preliminary studies utilizing
immunohistochemical approaches to examine neuroanatomical
associations between HSD2 and ERα in the hypothalamus.
We also explored the possibility of indirect interactions by
examining relationships between hypothalamic HSD2 and OT or
catecholamines.
Methods
Animals, Surgeries, and Hormone Replacement
Adult female and male Sprague-Dawley rats (Charles River),
90 days of age, were individually housed in plastic cages in
a temperature-controlled colony room on a 12:12 light:dark
cycle with lights on at 07:00. Rats were adapted to the
colony room for a minimum of 7 days before any procedures
were initiated and were given ad libitum access to Harlan
rodent diet (no. 2018) and deionized water throughout the
study. All procedures were approved by the Oklahoma State
University—Center for Health Sciences Institutional Animal
Care and Use Committee.
Female rats were bilaterally OVX under pentobarbital
anesthesia (Sigma; 50 mg/kg, ip). After a week of recovery,
OVX rats received subcutaneous injections of the oil vehicle
(OIL; 0.1 ml; n = 6) or 17-β-estradiol-3-benzoate (EB; Fisher;
10 µg in 0.1 ml oil; n = 7) on Day 1 and Day 2 of a
4-day replacement protocol. This protocol, based on studies
by Woolley and McEwen (1993), has been used extensively
in neuroanatomical and behavioral studies (e.g., Woolley and
McEwen, 1993; Kisley et al., 1999) including those from our
lab (Krause et al., 2006; Fan et al., 2010; Graves et al.,
2011).
Male rats (n = 5) did not undergo surgery; however, three
males received subcutaneous injections of the oil vehicle (0.1 ml)
on the same 4-day protocol as OVX rats, while twomale rats were
untreated. No differences in any measures were observed due to
oil treatment of male rats.
Perfusion, Brain Collection, and Sectioning
OVX and male rats that were given EB or oil injections
were weighed on Day 1 and 2, and again on Day 4, after
which they were deeply anesthetized with pentobarbital (25
mg/rat). Rats then were perfused transcardially with 0.15 M
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NaCl followed by 4% paraformaldehyde. Brains were removed,
postfixed in 4% paraformaldehyde overnight, and then stored
in 30% sucrose at 4◦C. Brains were cut into a 1:3 series of 40-
µm sections using a cryostat (Leica); sections were stored in
a cryoprotectant solution (Watson et al., 1986) at −20◦C until
processed.
Untreated male rats were weighed only on the day of sacrifice,
and then were anesthetized and perfused as described.
Body Weight and Uterine Weight
Changes in body weight during the 4-day protocol were
assessed for OVX and male rats that were given EB or oil
injections by calculating the percent change in body weight from
Day 4 to Day 1.
After perfusion onDay 4, uterine weights were assessed from a
subset of OVX rats (OIL: n = 4; EB: n = 5). For each rat, the uterus
was removed and stripped of fat. A 10-cm segment of one uterine
horn beginning at the bifurcation then was cut and weighed.
Immunolabeling
Free-floating forebrain sections were rinsed in 0.05 M Tris-NaCl,
followed by 30 min in 0.5% H2O2, and then were rinsed in 0.05
M Tris-NaCl before being incubated for 1 h in 10% normal goat
serum (NGS) mixed in 0.5% Triton X in 0.05 M Tris-NaCl. One
series of sections from subsets of rats then was processed to label
markers of various neuronal phenotypes using immunolabeling
procedures described below.
Upon completion of immunolabeling, tissue was rinsed
in 2% NGS, and then in 0.05 M Tris-NaCl. Sections from
each animal were ordered, mounted on gelatin-coated glass
microscope slides, and allowed to dry. Slides then were briefly
immersed in distilled water, then dehydrated in an ascending
series of ethanols (70%, 95%, 100%), and defatted in xylenes
before coverslipping with Cytoseal 60 (Fisher Thermo Scientific).
Immunolabeling was examined using a Nikon Eclipse 80i
epifluorescent microscope equipped with a camera, FITC and
rhodamine filters, and NIS Elements software.
ERα Immunolabeling
Sections were incubated in the primary antibody (Millipore;
rabbit anti-ERα C1355; MM_NF-06-935)1 diluted 1:10, 000 in
2%NGS for 1 h at room temperature, and then for approximately
70 h at 4◦C. On the second day of processing, tissue was
brought to room temperature for 1 h and then rinsed in 2%
NGS. Sections were then incubated for approximately 5 h in the
secondary antibody (Jackson Immunoresearch; goat anti-rabbit
Cy2) diluted 1:300 in 2% NGS.
Despite targeted elimination of ERα in the VMH, rats
nonetheless decrease feeding in response to estradiol treatment
(Musatov et al., 2007), suggesting that additional populations
of ERα are involved in the control of feeding. Accordingly, in
addition to assessment of ERα in the VMH, we also assessed
the possibility of HSD2-ERα associations in the adjacent ARC,
which also has been implicated in the control of feeding (Woods
1http:// www.emdmillipore.com/US /en/product/Anti-Estrogen -Receptor-%
CE%B1-Antibody,MM_NF-06-935#anchor_COA; NG1838275
and Stricker, 2008). ERα-immunoreactivity was visualized in
2–3 representative sections from the ARC and VMH of each
rat based on neuroanatomical landmarks and coordinates as
described by Paxinos and Watson (Paxinos and Watson, 1998)
(−2.30 to −3.30 mm relative to bregma; see Figure 1A). These
sections were matched between subjects and, with exposure time
held constant, digital photomicrographs from one side of each
section were taken and saved for later quantification of ERα-
immunoreactive neurons. Counts from each area were averaged
for each rat, and group means for each area (Male: n = 5;
OIL: n = 5–6; EB: n = 7) were calculated from the averaged
counts.
HSD2 Immunolabeling
As described in our previous publication (Fan et al., 2010),
sections were incubated in the primary antibody (SantaCruz;
rabbit anti-HSD2)2 diluted 1:500 in 2% NGS for 1 h at
room temperature, and then for approximately 48 h at 4◦C.
On the second day of processing, tissue was brought to
room temperature for 1 h, rinsed in 2% NGS, and then
incubated for approximately 5 h in the secondary antibody
(Jackson Immunoresearch; goat anti-rabbit Cy3) diluted 1:200 in
2% NGS.
HSD2-immunoreactivity was visualized in the hypothalamus
at the approximate level of the ventromedial nucleus (VMN).
Putative HSD2-immunoreactive neurons were identified
based on morphology (intense, cytoplasmic staining with
prominent projections; see Figure 2A) and, with exposure
time held constant, digital photomicrographs were taken
from one side in each of 2–3 representative sections that
were matched between subjects. These micrographs were
saved for later quantification of HSD2 neurons. Counts
were averaged for each rat, and group means (Male: n = 5;
OIL: n = 3; EB: n = 7) were calculated from the averaged
counts.
HSD2 Double-Immunolabeling
After HSD2-immunolabeling, tissue from subsets of these
rats was rinsed in 2% NGS and then processed to identify
additional neuronal phenotypes. Given that HSD2-labeling was
sparse in both male and OIL-treated OVX rats (Figure 2D),
we focused on double-immunolabeling in EB-treated OVX
rats. It should be noted that the primary antibodies for both
ERα and HSD2 were raised in rabbit, thereby precluding
double-immunolabeling for ERα and HSD2 using these
techniques.
HSD2 and Tyrosine Hydroxylase (TH)
After HSD2-immunolabeling, forebrain sections from EB-
treated rats (n = 6) were processed to visualize catecholaminergic
neurons and fibers in the hypothalamus at the level of the
VMH by immunolabeling for tyrosine hydroxylase (TH), the
rate limiting enzyme in catecholamine biosynthesis. Sections
were incubated in the primary antibody (Millipore; mouse
2http://datasheets.scbt.com/sc-20176.pdf
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FIGURE 1 | ERα neurons in the hypothalamus. (A) Atlas drawing (adapted
from Paxinos and Watson, 1998) showing approximate location of
ERα-containing neurons (green shading) in the Arcuate nucleus (ARC) of the
hypothalamus and the Ventromedial hypothalamus (VMH); (B) digital
photomicrograph (scale bar = 100 µm) of ERα-immunolabeled neurons in the
ARC and VMH. Graphs showing mean numbers of ERα-immunolabeled
neurons in (C) the VMH and (D) ARC of male rats (white bars; n = 5–6), and of
ovariectomized (OVX) rats given the oil vehicle (OIL; gray bars; n = 5–6) or
estradiol benzoate (EB; black bars; n = 7). **significantly greater than Male (p <
0.01). ***significantly greater than Male (p < 0.001).
anti-TH; MM_NF-MAB318)3 diluted 1:5000 in 2% NGS for
1 h at room temperature, and then for approximately 48 h
at 4◦C. On the second day of processing, tissue was brought
to room temperature for 1 h, rinsed in 2% NGS, and then
incubated for approximately 5 h in the secondary antibody
(Jackson Immunoresearch; goat anti-mouse Cy2) diluted 1:300
in 2% NGS.
HSD2 and Oxytocin (OT)
After HSD2-immunolabeling, forebrain sections from EB-
treated rats (n = 5) were processed to visualize oxytocinergic
neurons and fibers in the hypothalamus at the level of the VMH
and extending rostrally to the paraventricular nucleus (PVN)
and supraoptic nucleus (SON) of the hypothalamus (−2.12 to
3http://www.emdmillipore.com/US/en/product/Anti-Tyrosine-Hydroxylase-
Antibody,MM_NF-MAB318#anchor_COA; LV1594176
−0.80 mm relative to bregma; see Figure 4A). Sections were
incubated in the primary antibody (Chemicon; mouse anti-OT;
MM_NF-MAB5296)4 diluted 1:25000 in 2% NGS for 1 h at
room temperature, and then for approximately 48 h at 4◦C.
On the second day of processing, tissue was brought to room
temperature for 1 h, rinsed in 2% NGS and then incubated for
5 h in the secondary antibody (Jackson Immunoresearch: goat
anti-mouse Cy2) diluted 1:300 in 2% NGS.
For analyses of double-immunolabeling, NIS Elements
software was used to overlay fluorescent images. HSD2-labeling
appeared as bright red cytoplasmic labeling in putative HSD2
neurons (Figures 2A,B); TH- or OT-labeling appeared as
bright green labeling in catecholaminergic (Figures 3B–D) or
4http://www.emdmillipore.com/US/en/ product/ Anti-Oxytocin-Antibody%
2C-clone-4G11,MM_NF-MAB5296#anchor_COA; 1979939
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FIGURE 2 | HSD2 neurons in the hypothalamus. (A) High magnification
digital photomicrographs (scale bars = 20 µm) showing the morphology of
HSD2-immunolabeled neurons in the hypothalamus; (B) digital
photomicrograph (scale bar = 50 µm) of HSD2-immunolabeled neurons in the
hypothalamus of an OVX rat given estradiol-benzoate and (C) atlas drawing
(adapted from Paxinos and Watson, 1998) showing approximate location of
HSD2-containing neurons (red shading) and ERα-containing cells (green
shading) in the hypothalamus. (D) Graph showing mean number of
HSD2-immunolabeled neurons in the hypothalamus of male rats (white bars;
n = 5), and of OVX rats given oil vehicle (OIL; gray bars; n = 3) or estradiol
benzoate (EB; black bars; n = 7). ***significantly greater than Male and OIL
(both ps < 0.001).
oxytocinergic neurons or fibers (Figures 4B–D). In merged
images, therefore, both green and red labeling could be observed
(e.g., Figures 3E,E’,F).
Statistical Analysis
All values are shown as group means ± standard errors of the
mean. Uterine weights were analyzed using a 2-tailed t-test.
Percent change in body weight, numbers of ERα-immunolabeled
neurons in the VMH, numbers of ERα-immunolabeled neurons
in the ARC, and numbers of HSD2-immunolabeled neurons
each were analyzed using 1-way Analysis of Variance (ANOVA)
with group (EB, OIL, MALE) as a factor. Pairwise comparisons
of statistically significant effects were further examined using
Fisher’s LSD tests.
Results
Body Weight and Uterine Weight
Body weight of the three groups on Day 1 and Day 4 are
presented in Table 1, along with the percent change from
Day 1 to Day 4. As expected (Wade, 1972; Blaustein and
Wade, 1976; Roy and Wade, 1977; Geary and Asarian, 1999;
Krause et al., 2006; Graves et al., 2011), EB-treated rats lost
weight during the 4-day protocol. One-way ANOVA indicated
a significant effect of group on the percent change in body
weight (F2,13 = 70.832, p < 0.001), and pairwise comparisons
revealed that the percent change in EB-treated OVX rats was
significantly less than that after oil injections in male rats
and in OVX rats (both ps < 0.001). Although male rats and
OIL-treated OVX rats gained weight during the protocol, the
percent change was significantly greater (p < 0.01) in male
rats.
EB treatment also had the expected effect on uterine weight
(Graves et al., 2011). As shown in Table 1, uterine weight in EB-
treated OVX rats was significantly greater (p< 0.01) than that in
OIL-treated OVX rats.
Immunolabeling
ERα
Figures 1A,B shows a schematic of the approximate location
of ERα-labeled cells in the VMH and ARC, along with a
representative digital photomicrograph of ERα-immunolabeling
in these areas. Mean numbers of ERα-labeled cells in the VMH
and ARC are given in Figures 1C,D. One-way ANOVA indicated
no effect of group on the number of ERα-labeled cells in
the VMH. In contrast, numbers of ERα-labeled cells in the
ARC depended on group (F2,15 = 13.884, p < 0.001). Pairwise
comparisons revealed greater numbers of ERα-labeled cells in
both EB-treated (p < 0.001) and OIL-treated (p < 0.01) OVX
rats compared to those in Male rats, but no differences between
EB- and OIL-treated rats.
HSD2
Figures 2B,C shows a representative digital photomicrograph
of the cluster of HSD2-immunolabeled neurons in the
hypothalamus of an EB-treated OVX rat, along with a
schematic of their approximate location. The cluster of
HSD2-labeled neurons was anatomically segregated from
and lateral to the populations of ERα-labeled cells in both
the ARC and the VMH, as indicated on the schematic. Mean
numbers of HSD2-labeled neurons are given in Figure 2D.
One-way ANOVA indicated a significant effect of group
on the number of HSD2-labeled neurons (F2,12 = 63.285,
p < 0.001), and pairwise comparisons revealed that the
number of HSD2-labeled neurons in EB-treated OVX rats
(37.5 ± 2.7 neurons) was significantly greater than those in
OIL-treated OVX and male rats (both ps < 0.001). In fact,
there were few HSD2-labeled neurons in either male rats
or OIL-treated OVX rats (less than eight and five neurons,
respectively), and the numbers did not differ between these two
groups.
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FIGURE 3 | Catecholamines in the hypothalamus. (A) Atlas drawing
(adapted from Paxinos and Watson, 1998) showing approximate locations
of catecholamine neurons and fibers (green shading) in the hypothalamus.
Digital photomicrographs (scale bars = 100 µm) of tyrosine hydroxylase
(TH)-immunolabeled neurons in (B) the A13 region of the hypothalamus
and (C) the Arcuate Nucleus (ARC), and TH-immunolabeled fibers (D) in
the medial forebrain bundle (MFB). Merged digital photomicrographs
(Continued)
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FIGURE 3 | Continued
(scale bars = 50 µm, 20 µm) of immunolabeling for HSD2 (red) and TH (TH;
green). (E) TH-immunolabeled fibers within a population of HSD2-
immunolabeled neurons. Area in box on left is shown at higher magnification
on the right (E’). (F) HSD2- and TH-immunolabeled neurons in close proximity.
HSD2 and TH
Figure 3A shows a schematic of the approximate location
of TH-labeled neurons and fibers in several areas of the
hypothalamus at the level of the VMN. Also shown are
representative digital photomicrographs (Figures 3B–D) of
TH-immunolabeled neurons in the A13 catecholamine cell
group and in the ARC, as well as TH-labeled fibers of the
medial forebrain bundle (MFB). Although TH-immunolabeled
neurons in the ARC and the A13 region display prominent
projections, they did not appear to extend into the cluster
of HSD2-labeled neurons. Similarly, the large aggregate of
TH-labeled fibers which comprise the MFB did not appear
to project to HSD2-labeled neurons. Nonetheless, merged
digital photomicrographs of TH- and HSD2-immunolabeling
showed a sparse incursion of TH-labeled fibers into the
area of HSD2-labeled neurons, some of which appeared to
contact HSD2-labeled neurons (Figures 3E,E’). In a few isolated
cases, neurons labeled for TH or for HSD2 were observed
in close proximity, though clearly were different neurons
(Figure 3F).
HSD2 and OT
Figures 4A–D shows a schematic of the approximate location
of OT-labeled neurons in several areas of the hypothalamus,
along with representative digital photomicrographs of OT-
immunolabeled neurons in the PVN, Nucleus Circularis, and
SON. In general, these neurons did not display conspicuous
projections, though punctate OT-labeling was observed in
the median eminence, as expected (not shown). Nonetheless,
there did not appear to be OT projections to the cluster
of HSD2-labeled neurons, as evidenced by the merged
digital photomicrograph of OT- and HSD2-immunolabeling
(Figure 4E).
Discussion
Based on previous reports of estradiol-mediated changes in
the number of HSD2-containing neurons in the NTS (Fan
et al., 2010), the presence of HSD2-containing neurons in
the VMH (Geerling et al., 2006b), and the involvement of
ERα in the VMH in the regulation of food intake (Musatov
et al., 2007), we hypothesized that HSD2-containing neurons
in the hypothalamus contribute to centrally-mediated control
of feeding by direct interactions with ERα or by indirect
interactions with other neurotransmitters previously shown to
play a role in feeding. Thus, in this initial approach, we
opted to use immunohistochemical methods and focused on
neuroanatomical associations between HSD2 and ERα, OT,
and catecholamines. Our rationale in these studies rested on
the hypothesized co-segregation of HSD2 and ERα in the
VMH, which clearly was not found. However, an important
caveat to this rationale is that, despite targeted elimination
of ERα in the VMH, rats nonetheless decrease feeding
in response to estradiol treatment (Musatov et al., 2007),
suggesting that additional populations of ERα are involved
in the control of feeding. With this in mind, we included
the adjacent ARC, which also has been implicated in feeding
(Woods and Stricker, 2008), in our assessment of HSD2-ERα
associations.
The results were unexpected on several levels. First, HSD2-
containing cells with a clear neuronal profile were located
as an aggregate in more lateral regions of the hypothalamus.
HSD2 immunolabeling previously was reported to occur in
the VMH (Geerling et al., 2006b), and we also observed
more widespread nuclear HSD2-labeling in the medial parts
of the hypothalamus, particularly in close proximity to the
third ventricle. However, the HSD2-immunolabled cells that
exhibited a distinct neuronal morphology were concentrated
in the lateral hypothalamus, and, surprisingly, were observed
primarily in EB-treated OVX rats. It is possible that different
antibodies employed differentially recognize slightly different
epitopes with discrete cellular localizations. Alternatively, our
investigation of estrogen-mediated sex differences in this
neuronal phenotype may have allowed the detection of this
more laterally located population. In either case, we opted to
focus on this aggregate of HSD2-containing neurons, which
were anatomically segregated from the ERα-immunolabeled
cells in both the VMH and the ARC. Thus, if these
HSD2-containing neurons interact with ERα to decrease
feeding, it is not via co-localization with populations of
ERα-containing neurons located in either the VMH or the
ARC.
TABLE 1 | Body weight and uterine weight.
Male OIL EB
Body weight (g) Day 1 367.7 ± 12.5 263.5 ± 8.4 278.7 ± 9.5
Day 4 396.0 ± 13.5 272.5 ± 28.5 268.9 ± 9.5
% change 7.71 ± 0.43 3.44 ± 0.731 −3.55 ± 0.532
Uterine weight (mg/10 cm) 39.5 ± 8.0 93.6 ± 9.23
Body weight and body weight change in ovariectomized (OVX) rats given oil vehicle (OIL; n = 6) or estradiol benzoate (EB; n = 7) and in male rats given oil vehicle (Male;
n = 3) during the 4-day protocol. Body weight of Male rats that were not given oil vehicle are not included in Table 1; however, on Day 4, body weight of all males included
in this study (n = 5) was 422.8 ± 8.5 g. Uterine weights were determined in a subset of OVX rats at sacrifice (OIL: n = 4, EB: n = 5). 1significantly less than Male (p <
0.01); 2significantly less than Male and OIL (both ps < 0.001); 3significantly greater than OIL (p < 0.001).
Frontiers in Systems Neuroscience | www.frontiersin.org 7 June 2015 | Volume 9 | Article 91
Askew et al. Hypothalamic HSD2 neurons and their interactions
FIGURE 4 | Oxytocin (OT) in the hypothalamus. (A) Atlas drawing
(adapted from Paxinos and Watson, 1998) showing approximate locations
of OT neurons (green shading) in the hypothalamus. Digital
photomicrographs (scale bars = 50 µm, 100 um) of OT immunolabeled
neurons in (B) the Paraventricular nucleus (PVN), (C) the Nucleus
Circularis, (D) the Supraoptic nucleus (SON). (E) Merged digital
photomicrograph (scale bar = 50 µm) of immunolabeling for HSD2 (red)
and OT (green).
Nonetheless, the numbers of HSD2-containing neurons
were profoundly influenced by estradiol, a finding similar
to our observations of estradiol-induced effects on HSD2-
containing neurons in the hindbrain (Fan et al., 2010). It
is unclear at present what mechanism underlies this effect
in either area. There was scattered ERα immunolabeling in
more lateral areas of the hypothalamus in addition to the
dense populations in the VMH and ARC, so the striking
increase in the number of HSD2-containing neurons in
the more lateral hypothalamus may be attributable to an
ERα-mediated increase in gene expression in this population
of neurons. Alternatively, the β subtype of ERs may be
critical in increasing the number of HSD2-containing neurons,
nor can we rule out effects attributable to the g-protein
coupled ERs. Finally, ‘‘upstream’’ changes in a neuronal
circuit—potentially one that includes neurons in the VMH
or ARC—may impact this population of HSD2-containing
neurons.
We saw no differences in the number of ERα in the
VMH between the two groups of OVX rats, nor between
OVX rats and male rats. Given the well-known suppression
of feeding by estradiol (Wade, 1972; Blaustein and Wade,
1976; Roy and Wade, 1977; Geary and Asarian, 1999; Krause
et al., 2006), and previous findings of hyperphagia and body
weight gain when ERα in the VMH are depleted (Musatov
et al., 2007), along with reports that 72-h fasting decreases
ERα immunoreactivity in the VMH of OVX rats (Jones and
Wade, 2002), we expected that food intake by these groups
would be related to the number of ERα in the VMH. Clearly,
that expectation was not met. It is possible that ERα in the
VMH do not underlie differences in feeding by rats under
baseline conditions. Instead, their influence may be revealed only
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when the entire population is eliminated, and food intake and
body weight increase to extreme levels. Even then, however,
rats appear to retain some level of responsiveness to estradiol
(Musatov et al., 2007), which points to a complex interplay
among central populations of ERα. Consistent with this idea,
we observed sex differences in the number of ERα in the
ARC, another important central area in the regulation of
feeding (Woods and Stricker, 2008), and in which fasting has
been reported to decrease ERα immunoreactivity (Jones and
Wade, 2002). However, under ad libitum feeding conditions
used in our study, the difference in ERα numbers was sex-
but not estrogen-dependent and, presumably, was not related
to feeding. Thus, an alternative, and not mutually exclusive,
possibility is that the sensitivity of ERα is the critical factor
in the effect of estradiol to inhibit feeding, rather than the
number of ERα present in a particular area (or areas). On
the other hand, there may have been differences in the time
course of changes in ERα expression that we could not detect
with our 4-day EB-replacement protocol. Clearly, additional
studies with a broader array of pharmacological and molecular
biological approaches will be necessary to better understand
the role of these populations of ERα in the control of
feeding.
The observation that HSD2-containing neurons do not
co-segregate with ERα in the VMH or the ARC does not
in itself negate our hypothesis of a role for HSD2 in
the central control of food intake. Rather, the preferential
increase in numbers of these neurons by estradiol may allow
modulation of a hypothalamic circuit involved in feeding via
convergence of input to HSD2-containing neurons. Accordingly,
we also examined input to HSD2-containing neurons from
neurotransmitters that are known to play a role in the control
of feeding. OT inhibition of food intake requires release of
OT within the CNS and subsequent activation of central OT
receptors (e.g., Olson et al., 1991). Using immunohistochemical
methods, we saw no evidence of OT fibers in the vicinity
of HSD2-containing neurons, whereas OT projections were
apparent in the median eminence. On the surface, these
findings might seem to suggest that OT input to HSD2
neurons is not associated with the inhibition of feeding.
However, mismatch between projections and receptors have
been reported for the OT system in other parts of the CNS
(see Sabatier et al., 2013 for review). Thus, the possibility of
volume transmission of OT to activate receptors on HSD2-
containing neurons cannot be ruled out, particularly since
OT binding in the VMH has been reported to increase with
administration of estrogen (Tribollet et al., 1990; Arsenijevic
et al., 1995). Additional studies will be necessary to determine
more conclusively whether OT and HSD2 interact in the
hypothalamus.
In terms of catecholamines, noradrenaline signaling in the
hypothalamus has been shown to contribute to hyperphagia
via interactions with leptin and/or NPY (see Wellman, 2000
for review); however, the possibility of dopaminergic signaling
associated with the rewarding aspects of food intake also exists
(Palmiter, 2007). Merged images revealed close apposition of
TH-immunolabled fibers with HSD2 neurons in EB-treated
rats that could indicate synaptic contacts. TH-immunolabeled
fibers in the vicinity of HSD2-containing neurons were sparse;
nonetheless, these findings suggest the possibility of interactions
between catecholamines and HSD2 in the control of feeding.
However, more detailed analysis using, e.g., confocal microscopy
will be necessary to determine more conclusively whether
these appositions are, in fact, synaptic contacts. In short,
additional studies will be necessary to determine whether TH-
immunolabled fibers do, in fact, synapse on HSD2-labeling
neurons. If so, subsequent studies may focus on identifying
which catecholamine, the receptor mechanism by which HSD2
neuronal responses may be affected and, most important
for our hypothesis, the influence of such responses on food
intake.
In summary, we observed striking effects of estradiol
treatment on the number of HSD2-containing neurons
in the more lateral hypothalamus, but no evidence for a
direct associations between hypothalamic HSD2 and ERα
or HSD2 and OT. Neuroanatomical associations between
hypothalamic HSD2 and catecholamines are modest and
subject to verification of synaptic contacts. Thus, these studies,
which began with the hypothesis that HSD2-containing
neurons in the hypothalamus contribute to the control of
feeding via associations with ERα or other neurotransmitters,
did not conclusively identify a candidate neuroanatomical
substrate that would support this hypothesis. Nonetheless,
some possibilities have been identified that bear further
investigation. At the same time, it is clear that subsequent
studies using pharmacological and/or molecular biology
methods will be necessary to determine whether these HSD2-
containing neurons do, in fact, influence feeding under
conditions of elevated estradiol and whether catecholamines are
involved.
We end with the acknowledgment that despite our hypothesis
of a role for hypothalamic HSD2-containing neurons in
the control of feeding, and preliminary evidence from
these pilot studies, other possibilities remain. First, given
that HSD2 is a signature of aldosterone-sensitive tissues,
HSD2 neurons in the lateral hypothalamus may serve as a
target for aldosterone in the forebrain, and activity in this
hypothalamic population may be related to body sodium
homeostasis, as it is in the hindbrain (Geerling et al., 2006a;
Geerling and Loewy, 2007). An intriguing alternative, given
the role of HSD2 in the interplay between glucocorticoids
and mineralocorticoids (Náray-Fejes-Tóth et al., 1998), is that
the hypothalamic population of HSD2-containing neurons
alters stress responsiveness in the presence of estradiol (e.g.,
Solomon and Herman, 2009). Finally, the estradiol sensitivity
of this population and the known role of the VMH in sexual
behavior (e.g., Flanagan-Cato, 2011) raise the possibility that
hypothalamic HSD2-containing neurons may contribute
to the control of reproductive behaviors. Clearly, further
investigations are necessary to understand the functional role
of HSD2-containing neurons in the hypothalamus, as well
as the implications of the estradiol-mediated changes in the
numbers of these neurons in the hypothalamus and in the
hindbrain.
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